News | November 15, 2006

FDA Clears MR Analysis Software Created at Johns Hopkins

Diagnosoft, Inc. has received FDA approval for its HARP software that assists physicians in the analysis of magnetic resonance (MR) images by providing quantitative measurements and visualization of regional heart function.

Developed at and licensed from Johns Hopkins University, the technology is the first FDA approved software designed for the analysis of tagged MR images.

"Robust image analysis methods applied to so-called "tagged" MR images provide cardiologists and radiologists with a powerful tool for the measurement and visualization of cardiac muscle performance -- that is, regional cardiac function -- at a level that has not been possible before," said Dr. Jerry Prince, PhD, Diagnosoft founder and professor at JHU. "Radiologists have been limited to the visual analysis of MR images in order to detect weaknesses or abnormalities in the heart muscles. With the Diagnosoft HARP software, images can now be automatically analyzed to reveal a quantitative measure of function and these measures can be visualized on a standard map designed to help physicians correlate abnormalities with coronary arteries that could be blocked."

Diagnosoft HARP is now cleared for clinical applications and can be used by radiologists, cardiologists, and pharmaceutical companies in assisting the diagnosis, staging and monitoring heart disease as well as in the development of new therapies. The company begins selling HARP version 1.1 this month.

Drs. Nael Osman and Jerry Prince, both founders of Diagnosoft, developed the HARP algorithm at Johns Hopkins University, where they are both currently on the faculty and experts in medical image analysis. Dr. Matthias Stuber, also a founder and faculty member at JHU, brings additional expertise in MR imaging to the company.

For more information visit www.diagnosoft.com.

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
GE Healthcare's Signa Premier MRI Receives FDA 510(k) Clearance
Technology | Magnetic Resonance Imaging (MRI)| August 04, 2017
GE Healthcare announced Signa Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available...
Cardiac CT scan showing plaque and calcification in the coronary arteries, from a Toshiba CT scanner
News | Business| July 19, 2017
July 19, 2017 — The Society of Cardiovascular Computed Tomography (SCCT) created a reimbursement fee chart for cardia
German Workshop Highlights Possibilities of Perfusion MRI
News | Stroke| July 03, 2017
When diagnosing strokes and heart diseases or looking at tumors, perfusion magnetic resonance imaging (MRI) offers a...
Sponsored Content | Videos | Clinical Decision Support| June 29, 2017
Rami Doukky, M.D., system chair, Division of Cardiology, professor of medicine, Cook County Health and Hospitals Syst
Toshiba Medical Introduces Vantage Titan Zen Edition MR
Technology | Magnetic Resonance Imaging (MRI)| June 27, 2017
June 27, 2017 — Toshiba Medical, a Canon Group company, introduced its newest...
HRS released a consensus statement on MRI for patients with cardiac implantable electronic devices
Feature | May 15, 2017
May 15, 2017 — The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement in the United States o
Biotronik Launches First FDA-Approved CRM Devices with MRI AutoDetect Technology
Technology | Cardiac Resynchronization Therapy Devices (CRT)| May 10, 2017
Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved cardiac rhythm...
Overlay Init